- a brief background on biosimilars within oncology;
- experiences and perspectives of use, including barriers and hurdles;
- reflections of the economic impact; and
- expectations and needs for the future.
Giuseppe Curigliano is Full Professor of Medical Oncology at the University of Milano and Head of the Clinical Division of Early Drug Development at the European Institute of Oncology (IEO), Milan, Italy. He serves as a member of the Italian Higher Health Council and serves the European Society for Medical Oncology (ESMO) as Chair of the Clinical Practice Guidelines Committee.
This was funded by an educational grant from Pfizer, who has no input to the creation of this educational webinar